US Stocks
/
Cassava Sciences, Inc. Share Price
Cassava Sciences, Inc. Share Price

Cassava Sciences, Inc. Share Price

NASDAQ: SAVA
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cassava Sciences, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Cassava Sciences, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Cassava Sciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-0.53
Revenue (TTM)
N/A
Return On Equity (TTM)
-16.71%
Profit Margin
N/A
Debt to Equity
0.08
Quarterly Earnings Growth YoY
61.32%

Cassava Sciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit$25.04M$6.16M-$27.94M-$23.40M-$44.22M-$10.81M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-75.42%-553.99%16.25%-88.97%75.56%

Cassava Sciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232024
RevenueN/AN/AN/AN/A
Net Profit-$32.38M-$76.25M-$97.22M-$24.34M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-135.44%-27.50%74.96%

About Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Cassava Sciences, Inc. Historical Returns

MonthOpenCloseChange %

SAVA Share Price FAQs

What is Cassava Sciences, Inc. share price today?

chevron-up
Cassava Sciences, Inc. share price today is $0.00 as on September 20, 2026 at 8:41 pm IST.

What is the 52 week high and 52 week low of Cassava Sciences, Inc. stock?

chevron-up
52 week high/low data for Cassava Sciences, Inc. is currently unavailable.

What is SAVA's net income for the last quarter?

chevron-up
SAVA's net income for the last quarter is -0.01B USD.

Can I buy SAVA shares in India?

chevron-up
Yes. You can buy SAVA in India by opening an international trading account.